RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0043-1777780
COVID-19-Related Brief Insomnia in a 13-Year-Old Adolescent Girl
Financial Support No financial support was provided for this case report.
Abstract
Neuropsychiatric manifestations that have developed after coronavirus disease 2019 (COVID-19) infection have not been fully clarified yet. Persistent insomnia and consequent significant impairment in daily functioning is an unexpected symptom of COVID-19 infection. In this case report, a 13-year-old female patient who presented with complaint of insomnia starting with COVID-19 infection is discussed. The patient showed significant improvement with melatonin treatment and maintained her wellbeing in the follow-up. Melatonin may be a useful option to treat COVID-19-related brief insomnia in adolescents. Our case report will be a step forward to help clinicians examine the underlying neurovegetative mechanisms, such as sleep, to improve patients wellbeing. HEADINGS: COVID-19. Melatonin. Sleep Initiation and Maintenance Disorders
Authors' Contributions
All authors have seen and approved the manuscript.
Publikationsverlauf
Eingereicht: 11. August 2022
Angenommen: 14. Februar 2023
Artikel online veröffentlicht:
29. Februar 2024
© 2024. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Riemann D, Baglioni C, Bassetti C. et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017; 26 (06) 675-700
- 2 de Zambotti M, Goldstone A, Colrain IM, Baker FC. Insomnia disorder in adolescence: Diagnosis, impact, and treatment. Sleep Med Rev 2018; 39: 12-24
- 3 Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11 (01) 16144
- 4 Bonati M, Campi R, Segre G. Psychological impact of the quarantine during the COVID-19 pandemic on the general European adult population: a systematic review of the evidence. Epidemiol Psychiatr Sci 2022; 31: e27
- 5 Bacaro V, Chiabudini M, Buonanno C. et al. Sleep Characteristics in Italian Children During Home Confinement Due to Covid-19 Outbreak. Clin Neuropsychiatry 2021; 18 (01) 13-27
- 6 Jones EAK, Mitra AK, Bhuiyan AR. Impact of COVID-19 on Mental Health in Adolescents: A Systematic Review. Int J Environ Res Public Health 2021; 18 (05) 2470
- 7 Panda PK, Gupta J, Chowdhury SR. et al. Psychological and Behavioral Impact of Lockdown and Quarantine Measures for COVID-19 Pandemic on Children, Adolescents and Caregivers: A Systematic Review and Meta-Analysis. J Trop Pediatr 2021; 67 (01) fmaa122
- 8 Fang H, Tu S, Sheng J, Shao A. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med 2019; 23 (04) 2324-2332
- 9 Nahidi M, Mokhber N, Sinichi F. et al. Mental Health Outcomes and Sleep Status among Patients with Coronavirus Disease 2019. Iran J Psychiatry 2022; 17 (03) 276-283
- 10 Biggio G, Biggio F, Talani G. et al. Melatonin: From Neurobiology to Treatment. Brain Sci 2021; 11 (09) 1121
- 11 Brandão LEM, Martikainen T, Merikanto I. et al. Social Jetlag Changes During the COVID-19 Pandemic as a Predictor of Insomnia - A Multi-National Survey Study. Nat Sci Sleep 2021; 13: 1711-1722
- 12 Morgenthaler TI, Lee-Chiong T, Alessi C. et al; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep 2007; 30 (11) 1445-1459
- 13 Bruni O, Angriman M, Calisti F. et al. Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities. J Child Psychol Psychiatry 2018; 59 (05) 489-508
- 14 Bueno APR, Savi FM, Alves IA, Bandeira VAC. Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review. Arq Neuropsiquiatr 2021; 79 (08) 732-742
- 15 Wei S, Smits MG, Tang X. et al. Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled trials. Sleep Med 2020; 68: 1-8
- 16 Zhang R, Wang X, Ni L. et al. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci 2020; 250: 117583
- 17 Wichniak A, Kania A, Siemiński M, Cubała WJ. Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders. Int J Mol Sci 2021; 22 (16) 8623
- 18 Bologna C, Madonna P, Pone E. Efficacy of Prolonged-Release Melatonin 2 mg (PRM 2 mg) Prescribed for Insomnia in Hospitalized Patients for COVID-19: A Retrospective Observational Study. J Clin Med 2021; 10 (24) 5857
- 19 Mousavi SA, Heydari K, Mehravaran H. et al. Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial. J Med Virol 2022; 94 (01) 263-271
- 20 Rogers JP, Chesney E, Oliver D. et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020; 7 (07) 611-627